Back

Development of a new score to predict left ventricular reverse remodelling in patients with nonischemic cardiomyopathy

28 August 2022 (14:15 - 15:00)
Organised by:
Congress Presentation Part of: Non-ischaemic cardiomyopathy: novel insights Dilated Cardiomyopathy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marcos Ferrandez

San Carlos Clinical University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Natural history of MYH7-related dilated cardiomyopathy
Doctor F. de Frutos Seminario (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Phenotypic variability of FLNC-related cardiomyopathy: insights from a novel Dutch founder variant
Mr S. Schoonvelde (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Natural history and clinical parameters of chemotherapy-induced dilated cardiomyopathy
Doctor E. Del Mestre (Trieste, IT)
Abstract Slides
Presentation thumbnail
Diagnostic pathways leading to arrhythmogenic left ventricular cardiomyopathy in a single center cohort
Doctor V. Parisi (Bologna, IT)
Abstract Slides
Presentation thumbnail
The joint role of collagen turn-over biomarkers and late gadolinium enhancement to predict cardiovascular outcome in nonischemic dilated cardiomyopathy
Doctor A. Zlibut (Muenster, DE)
Abstract Slides

Access the full session

Session thumbnail
Non-ischaemic cardiomyopathy: novel insights

The Event

Event poster

ESC Congress 2022

28 August 2022 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources